이 특허를 인용한 특허 (74)

1. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Maier, Roland, 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions.

   상세보기
2. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Maier, Roland, 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions.

   상세보기
3. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Maier, Roland, 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions.

   상세보기
4. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Mark, Michael; Maier, Roland; Lotz, Ralf; Tadayyon, Mohammad, 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions.

   상세보기
5. Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Mark, Michael; Maier, Roland; Lotz, Ralf; Tadayyon, Mohammad, 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions.

   상세보기
6. Klein, Thomas; Grempler, Rolf; Mark, Michael, Combination therapy.

   상세보기
7. Klein, Thomas; Grempler, Rolf; Mark, Michael, Combination therapy.

   상세보기
8. Klein, Thomas; Grempler, Rolf; Mark, Michael, Combination therapy.

   상세보기
9. Friedl, Thomas; Braun, Michael; Egusa, Kenji; Fujita, Hikaru; Maruyama, Megumi; Nishioka, Takaaki, DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation.

   상세보기
10. Friedl, Thomas; Braun, Michael; Egusa, Kenji; Fujita, Hikaru; Maruyama, Megumi; Nishioka, Takaaki, DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation.

    상세보기
11. Friedl, Thomas; Braun, Michael; Egusa, Kenji; Fujita, Hikaru; Maruyama, Megumi; Nishioka, Takaaki, DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation.

    상세보기
12. Klein, Thomas; Mark, Michael; Thomas, Leo, Diabetes therapy.

    상세보기
13. Rajewski, Lian G.; Rajewski, Roger A.; Haslam, John L.; Heppert, Kathleen; Beckloff, Michael C.; Seagrave, Frank; Mauro, Robert; Colabuono, Peter, Enalapril compositions.

    상세보기
14. Rajewski, Lian G.; Rajewski, Roger A.; Haslam, John L.; Heppert, Kathleen; Beckloff, Michael C.; Segrave, Frank; Mauro, Robert; Colabuono, Peter, Enalapril compositions.

    상세보기
15. Rajewski, Lian G.; Rajewski, Roger A.; Haslam, John L.; Heppert, Kathleen; Beckloff, Michael C.; Segrave, Frank; Mauro, Robert; Colabuono, Peter, Enalapril compositions.

    상세보기
16. Rajewski, Lian G.; Rajewski, Roger A.; Haslam, John L.; Heppert, Kathleen; Beckloff, Michael C.; Segrave, Frank; Mauro, Robert; Colabuono, Peter, Enalapril compositions.

    상세보기
17. Mosher, Gerold L.; Miles, David W., Enalapril formulations.

    상세보기
18. Mosher, Gerold L.; Miles, David W., Enalapril formulations.

    상세보기
19. Mosher, Gerold L.; Miles, David W., Enalapril formulations.

    상세보기
20. Mosher, Gerold L.; Miles, David W., Enalapril formulations.

    상세보기
21. , Formulations of ramipril.

    상세보기
22. Mosher, Gerold L.; Miles, David W., Lisinopril formulations.

    상세보기
23. Mosher, Gerold L.; Miles, David W., Lisinopril formulations.

    상세보기
24. Mosher, Gerold L.; Miles, David W., Lisinopril formulations.

    상세보기
25. Mosher, Gerold L.; Miles, David W., Lisinopril formulations.

    상세보기
26. Klein, Thomas; Advani, Andrew; Connelly, Kim Alexander; Gilbert, Richard Ernest, Medical use of a DPP-4 inhibitor.

    상세보기
27. Meinicke, Thomas; Von Eynatten, Maximilian, Medical use of pharmaceutical combination or composition.

    상세보기
28. Klein, Thomas; Mark, Michael, Method for modifying food intake and regulating food preference with a DPP-4 inhibitor.

    상세보기
29. Cooper, Vincent Brett; Bradley, Kathryn Alanna; Pygall, Samuel Robert; Gupta, Rajan; Stanford, Madison Paige; Xie, Lin, Oral pharmaceutical formulation of omarigliptin.

    상세보기
30. Ito, Masanori; Egusa, Kenji; Kleinbeck, Kyle; Messerschmid, Roman; Schneider, Peter; Voleti, Venkata, Pharmaceutical composition and uses thereof.

    상세보기
31. Bauer Brigitte,DEX ; Karlsson Christer,SEX ; Lundberg Per Johan,SEX ; Nilsson Berit,SEX ; Sandberg Anders,SEX ; Sickmuller Alfred,DEX, Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound.

    상세보기
32. Creekmore Joseph R ; Wiggins Norman A., Pharmaceutical compositions.

    상세보기
33. Creekmore, Joseph R; Wiggins, Norman A., Pharmaceutical compositions.

    상세보기
34. Sherman, Bernard Charles, Pharmaceutical compositions comprising moexipril magnesium.

    상세보기
35. Sherman, Bernard Charles, Pharmaceutical compositions comprising quinapril magnesium.

    상세보기
36. Sieger, Peter; Kemmer, Dirk; Kohlbauer, Peter; Nicola, Thomas; Renz, Martin, Polymorphs.

    상세보기
37. Sieger, Peter; Kemmer, Dirk; Kohlbauer, Peter; Nicola, Thomas; Renz, Martin, Polymorphs.

    상세보기
38. Sieger, Peter; Kemmer, Dirk; Kohlbauer, Peter; Nicola, Thomas; Renz, Martin, Polymorphs.

    상세보기
39. Pfrengle, Waldemar; Pachur, Thorsten; Nicola, Thomas; Duran, Adil, Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines.

    상세보기
40. Pfrengle, Waldemar; Pachur, Thorsten; Nicola, Thomas; Duran, Adil, Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines.

    상세보기
41. Pfrengle, Waldemar; Pachur, Thorsten; Nicola, Thomas; Duran, Adil, Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines.

    상세보기
42. Sieger, Peter; Pfrengle, Waldemar, Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine.

    상세보기
43. Sieger, Peter; Pfrengle, Waldemar, Salt forms of a xanthine compound.

    상세보기
44. Daniel,Jane Ellen; Harris,Michael Ray; Hokanson,Gerard Clifford; Weiss,Jay, Stabilization of quinapril using magnesium oxide.

    상세보기
45. Jane Ellen Daniel ; Michael Ray Harris ; Gerard Clifford Hokanson ; Jay Weiss, Stabilization of quinapril using magnesium oxide.

    상세보기
46. Apelian Vahe Henry ; Parikh Nilesh H. ; Iyer Raman, Stabilized pharmaceutical compositions.

    상세보기
47. Vivilecchia Richard V. ; Ross Bruce A., Stabilized pharmaceutical compositions comprising acid donors.

    상세보기
48. Vivilecchia Richard V. ; Ross Bruce A., Stabilized pharmaceutical compositions comprising acid donors.

    상세보기
49. Vivilecchia, Richard V.; Ross, Bruce A., Stabilized pharmaceutical compositions comprising acid donors.

    상세보기
50. Vivilecchia, Richard V.; Ross, Bruce A., Stabilized pharmaceutical compositions comprising acid donors.

    상세보기
51. Han Chien-Hsuan ; Liaw Gary, Stabilized pharmaceutical compositions containing bupropion hydrochloride.

    상세보기
52. Spireas, Spiridon, Stable formulations of ACE inhibitors, and methods for preparation thereof.

    상세보기
53. Spireas, Spiridon, Stable formulations of ACE inhibitors, and methods for preparation thereof.

    상세보기
54. Patel, Ashish Anilbhai; Davila, Pablo, Stable pharmaceutical compositions containing an ACE inhibitor.

    상세보기
55. Sherman Bernard Charles (Willowdale CAX), Stable solid formulation of enalapril salt and process for preparation thereof.

    상세보기
56. Bhushan Indu,INX ; Somani Jitendra Krishan,INX, Stable solid pharmaceutical compositions containing enalapril maleate.

    상세보기
57. Pfrengle, Waldemar; Frank, Markus; Klein, Thomas, Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions.

    상세보기
58. Pfrengle, Waldemar; Frank, Markus; Klein, Thomas, Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions.

    상세보기
59. Pfrengle, Waldemar; Frank, Markus; Klein, Thomas, Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions.

    상세보기
60. Hagner, Thomas, System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel.

    상세보기
61. Drake James Franklin, Topically applied clotting material.

    상세보기
62. Dugi, Klaus; Graefe-Mody, Eva Ulrike; Harper, Ruth; Woerle, Hans-Juergen, Treatment for diabetes in patients inappropriate for metformin therapy.

    상세보기
63. Dugi, Klaus; Graefe-Mody, Eva Ulrike; Harper, Ruth; Woerle, Hans-Juergen, Treatment for diabetes in patients inappropriate for metformin therapy.

    상세보기
64. Dugi, Klaus; Graefe-Mody, Eva Ulrike; Harper, Ruth; Woerle, Hans-Juergen, Treatment for diabetes in patients inappropriate for metformin therapy.

    상세보기
65. Dugi, Klaus, Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor.

    상세보기
66. Dugi, Klaus; Graefe-Mody, Eva Ulrike; Mark, Michael; Woerle, Hans-Juergen; Zimdahl-Gelling, Heike, Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin.

    상세보기
67. Dugi, Klaus; Graefe-Mody, Eva Ulrike; Mark, Michael; Woerle, Hans-Juergen; Zimdahl-Gelling, Heike, Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin.

    상세보기
68. Klein, Thomas; von Eynatten, Maximilian; Hocher, Berthold; Mark, Michael; Sharkovska, Yuliya, Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome.

    상세보기
69. Klein, Thomas; von Eynatten, Maximilian; Mark, Michael, Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome.

    상세보기
70. Sch��lkens,Bernward; Bender,Norbert; Rangoonwala,Badrudin; Dagenais,Gilles; Gerstein,Hertzel; Yusuf,Salim, Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events.

    상세보기
71. Dugi, Klaus; Himmelsbach, Frank; Mark, Michael, Uses of DPP IV inhibitors.

    상세보기
72. Dugi, Klaus; Himmelsbach, Frank; Mark, Michael, Uses of DPP IV inhibitors.

    상세보기
73. Klein, Thomas; Daiber, Andreas; Johansen, Odd-Eric; Mark, Michael; Patel, Sanjaykumar; Woerle, Hans-Juergen, Vasoprotective and cardioprotective antidiabetic therapy.

    상세보기
74. Roth,Bruce, [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof.

    상세보기
더보기